Press "esc" to clear
Go to Advanced Search

Showing results

110 of 976
george_chang.jpg
  • Embargo expired:
    22-May-2018 11:00 AM EDT

Article ID: 694921

Surveillance Intensity Not Associated with Earlier Detection of Recurrence or Improved Survival in Colorectal Cancer Patients

University of Texas M. D. Anderson Cancer Center

A national retrospective study led by researchers at The University of Texas MD Anderson Cancer Center found no association between intensity of post-treatment surveillance and detection of recurrence or overall survival (OS) in patients with stage I, II or III colorectal cancer (CRC). Published in the Journal of the American Medical Association, the study is the largest of surveillance intensity in CRC ever conducted.

Released:
22-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Sana.Karam.jpg

Article ID: 694872

Ice Cream Funds Research Showing New Strategy Against Thyroid Cancer

University of Colorado Cancer Center

University of Colorado Cancer Center study shows that stereotactic body radiation (SBRT) may be better against anaplastic thyroid cancer, and with fewer side effects.

Released:
21-May-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
surgery4shutterstock_672106594.jpg
  • Embargo expired:
    19-May-2018 12:30 PM EDT

Article ID: 694803

Analysis Shows Lymph Node Dissection Performed most often for Early Stage Kidney Cancer; Overall Survival Benefit not Shown

Rutgers Cancer Institute of New Jersey

An analysis of lymph node dissection in non-metastatic renal cell carcinoma indicates the procedure is often performed for stage 1 disease and shows no overall survival benefit. Investigators from Rutgers Cancer Institute of New Jersey presented the work at the Annual Meeting of the American Urological Association.

Released:
18-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
UCSD-JacobsSchool-20180514-LewisJean_dev-00572-8MP.jpg

Article ID: 694760

New Blood Test Rapidly Detects Signs of Pancreatic Cancer

University of California San Diego

UC San Diego researchers have developed a test that can screen for pancreatic cancer in just a drop of blood. The test, which is at the proof-of-concept stage, provides results in under an hour. It's simple: apply a drop of blood on a small electronic chip, turn the current on, wait several minutes, add fluorescent labels and look at the results under a microscope. If a blood sample tests positive for pancreatic cancer, bright fluorescent circles will appear.

Released:
17-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694748

Polly’s Run Races Against Pancreatic Cancer

University of New Mexico Comprehensive Cancer Center

Polly’s Run, a fundraiser to support pancreatic cancer research, will take place Sunday, June 3, at Tiguex Park near Albuquerque’s Old Town. The event will feature a 5K run/walk that starts at 8:30 a.m. and a Kid’s K that starts at 9:30 a.m. All proceeds benefit the Polly Rogers Pancreatic Cancer Research Fund at The University of New Mexico Comprehensive Cancer Center.

Released:
17-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
nurses_ONS.jpg

Article ID: 694732

Aiming to Improve Oncology Patient Outcomes Through Nursing Research

Rutgers Cancer Institute of New Jersey

From peer and patient education to addressing treatment side effects, nurses at Rutgers Cancer Institute of New Jersey researched a number of topics with an aim of enhancing the patient experience. Their findings are being presented at the Oncology Nursing Society’s Annual Congress.

Released:
17-May-2018 8:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694671

KU Medical Center Receives FDA Clearance to Proceed with Phase 1 Trial in Graft-versus-Host Disease Patients

University of Kansas Cancer Center

The University of Kansas Medical Center announced that the U.S. Food and Drug Administration (FDA) has cleared it to begin a first-in-human clinical trial of MSCTC-0010 in patients with de novo high-risk acute or steroid-refractory acute graft-versus-host disease (HR/SR aGvHD).

Released:
16-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694521

Seattle Cancer Care Alliance Opens One of the Nation’s First Programs for Patients with Inherited Blood Cancer

Seattle Cancer Care Alliance

Seattle Cancer Care Alliance (SCCA) recently opened the Hematologic Malignancy Genetics Clinic, which provides personalized risk assessment and follow-up care for adult patients and family members who may be at increased risk for developing hematologic malignancies due to an underlying genetic cause.

Released:
16-May-2018 9:20 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 694617

National Comprehensive Cancer Network Begins Work on Guidelines to Improve Cancer Care in the Caribbean

National Comprehensive Cancer Network® (NCCN®)

National Comprehensive Cancer Network collaborates with the Caribbean Association for Oncology & Hematology to create NCCN Harmonized Guidelines for the Caribbean

Released:
16-May-2018 9:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
main.jpg

Article ID: 694368

Research Finds 'Achilles Heel' for Aggressive Prostate Cancer

UCSF Helen Diller Family Comprehensive Cancer Center

UC San Francisco researchers have discovered a promising new line of attack against lethal, treatment-resistant prostate cancer. Analysis of hundreds of human prostate tumors revealed that the most aggressive cancers depend on a built-in cellular stress response to put a brake on their own hot-wired physiology.

Released:
14-May-2018 12:45 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 976





Chat now!